Home › Funds › PFM Health Sciences, LP › UTHR
PFM Health Sciences, LP position in UTHR
UNITED THERAPEUTICS CORP DEL · Health Care
PFM Health Sciences, LP reported holding 49,991 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q2 2026 13F filing — a position valued at US$27.1M, representing 2.37% of its reported portfolio and ranking #9 among its reported holdings. PFM Health Sciences, LP has disclosed UTHR holdings in 6 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PFM Health Sciences, LP's UTHR position evolved
PFM Health Sciences, LP first disclosed a stake in UTHR in Q4 2024 at 52,500 shares (US$18.5M). The position peaked in Q3 2025 at 95,650 shares, worth US$40.1M. Across 6 filings, PFM Health Sciences, LP increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 49,991 shares valued at US$27.1M — an increase of 18,291 shares quarter over quarter.. Notable position changes include a 163% increase in Q3 2025 (shares rose 16% over the following quarter), a 53% trim in Q1 2026 (shares fell 9% over the following quarter), a 58% increase in Q2 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 52.50K | $18.52M | New |
| Q2 2025 | 36.39K | $10.46M | New |
| Q3 2025 | 95.65K | $40.10M | Add |
| Q4 2025 | 67.74K | $33.01M | Reduce |
| Q1 2026 | 31.70K | $18.80M | Reduce |
| Q2 2026 | 49.99K | $27.09M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About UTHR and 13F data
UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 43 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), Renaissance Technologies (US$925.8M), ASSETMARK, INC (US$338.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding UTHR
- Avoro Capital Advisors LLC 2.78M sh · $1.51B · Q2 2026
- Renaissance Technologies 1.71M sh · $925.85M · Q2 2026
- ASSETMARK, INC 624.07K sh · $338.14M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 457.00K sh · $247.62M · Q2 2026
- Vestal Point Capital, LP 435.00K sh · $235.70M · Q2 2026
- Eversept Partners, LP 287.67K sh · $155.87M · Q2 2026
More on PFM Health Sciences, LP
FAQ
How long has PFM Health Sciences, LP held UTHR?
PFM Health Sciences, LP has disclosed UTHR holdings in 6 of the last 7 reported quarters, going back to Q4 2024.
What is PFM Health Sciences, LP's current position in UTHR?
As of Q2 2026, PFM Health Sciences, LP holds 49.99K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $27.09M, representing 2.37% of its reported portfolio and ranking #9.
Has PFM Health Sciences, LP been buying or selling UTHR?
In the latest 13F filing (Q2 2026), PFM Health Sciences, LP increased its position in UTHR. The position peaked in Q3 2025 at 95.65K shares.
Which other funds hold UTHR?
Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.